Pharmacokinetics (PK), Pharmacodynamics (PD) and Integrated PK/PD Modeling of a Novel Long Acting FGF21 Clinical Candidate PF-05231023 in Diet-Induced Obese and Leptin-Deficient Obese Mice

Podobne zapisy

• Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice.
  od: Yan Weng, i wsp.
  Wydane: (2015-01-01)
• Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study
  od: Dong, Jennifer Q, i wsp.
  Wydane: (2015)
• PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
  od: Thompson, W. Clayton, i wsp.
  Wydane: (2016)
• 1535. Pharmacokinetic (PK) and Pharmacodynamic (PD) Evaluation of Cefepime (CPM) in Obese and Non-Obese Patients
  od: Morrisette, Taylor, i wsp.
  Wydane: (2019)
• Pharmacokinetics (PK), Pharmacodynamics (PD), and PK-PD Integration of Danofloxacin in Sheep Biological Fluids
  od: Aliabadi, F. Shojaee, i wsp.
  Wydane: (2003)